Intra-tumoral distribution of 64Cu-ATSM: a comparison study with FDG
- 1 May 2003
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 30 (5) , 529-534
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Production of therapeutic quantities of 64Cu using a 12 MeV cyclotronNuclear Medicine and Biology, 2003
- Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent Cu-diacetyl-bis(N 4-methylthiosemicarbazone) (Cu-ATSM) in tumor cellsAnnals of Nuclear Medicine, 2001
- A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Copper-64-diacetyl-bis( N 4 -methylthiosemicarbazone): An agent for radiotherapyProceedings of the National Academy of Sciences, 2001
- Evaluation of62Cu labeled diacetyl-bis(N 4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancerAnnals of Nuclear Medicine, 2000
- High purity production and potential applications of copper-60 and copper-61Nuclear Medicine and Biology, 1999
- Efficient production of high specific activity 64Cu using a biomedical cyclotronNuclear Medicine and Biology, 1997
- Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumorsCancer, 1988
- Keynote address—the problem: Tumor radioresistance in clinical radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1982
- Isolated rat cardiac myocytes as an experimental tool in the study of anoxic cell injury. Effect of reoxygenation — A preliminary reportForensic Science International, 1980